EUVIMEDEUVIMED entdecken
Crossref

Integrative In Silico Pipeline for Discovering Natural SHP2 Allosteric Inhibitors Against Leukaemia

Manal A. Babaker, Mohammed A. Bazuhair

ChemistrySelect · 2026-05 · 11 (20)

DOI: 10.1002/slct.202502689 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemistrySelect, online erschienen am 21.05.2026. Verfasst von Manal A. Babaker und 1 weiteren Autor:innen. Die Arbeit nennt 79 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leukaemia presents a major clinical challenge due to genetic variability and drug resistance, highlighting the need for novel targeted treatments. Src homology 2 domain‐containing phosphatase 2 (SHP2), a key regulator of oncogenic signaling, has emerged as a promising target for allosteric inhibition. This study employed a comprehensive in silico pipeline to identify natural compound inhibitors of SHP2. An initial library of 3092 natural compounds was screened using Lipinski's Rule of Five, narrowing the list to 688 candidates with higher predicted activity than HET, a known SHP2 inhibitor. These were further analyzed using a Random Forest‐based QSAR model ( R 2 = 0.753), clustering, molecular docking, and density functional theory (DFT) calculations. From this, 25 top candidates were selected, and three, compounds 4806 , 18762634 , and 123631 , were identified as the most promising. Compound 4806 showed the strongest binding energy and stable interactions with SHP2 residues, as confirmed by molecular dynamics simulations and MM/GBSA binding energy (ΔTOTAL = −22.25 kcal/mol), comparable to the control. The findings suggest that compound 4806 is a strong candidate for SHP2 inhibition. Further in vitro and in vivo studies are recommended to validate its potential as a leukaemia therapy.

Zitieren

APA

Babaker, M. A., & Bazuhair, M. A. (2026). Integrative In Silico Pipeline for Discovering Natural SHP2 Allosteric Inhibitors Against Leukaemia. ChemistrySelect, 11(20). https://doi.org/10.1002/slct.202502689

Vancouver

Babaker MA, Bazuhair MA. Integrative In Silico Pipeline for Discovering Natural SHP2 Allosteric Inhibitors Against Leukaemia. ChemistrySelect. 2026;11(20). doi:10.1002/slct.202502689

BibTeX
@article{Babaker2026,
  author = {Babaker, Manal A. and Bazuhair, Mohammed A.},
  title = {Integrative In Silico Pipeline for Discovering Natural SHP2 Allosteric Inhibitors Against Leukaemia},
  journal = {ChemistrySelect},
  year = {2026},
  volume = {11},
  number = {20},
  doi = {10.1002/slct.202502689}
}
Kostenlos starten →